Jonathan M. Weiss
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jonathan M. Weiss has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Daniel W. McVicar
Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, Frederick MD 21702, USA
47 shared publications - Duncan Donohue
Statistical Consulting and Scientific Programming Group, Computer and Statistical Services, Data Management Services, Inc (a BRMI company), National Cancer Institute, Frederick, MD 21702, USA
42 shared publications - Esta Sterneck
Laboratory of Cell and Developmental Signaling; Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA
42 shared publications - Kuppusamy Balamurugan
Laboratory of Cell and Developmental Signaling; Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA
42 shared publications - Shikha Sharan
Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, Frederick MD 21702, USA
42 shared publications - Christopher W. Dell
CCR Volume Electron Microscopy (CVEM), Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
41 shared publications
Latest Publications
- Open Access
- 13 July 2026
- Published by Elsevier in SSRN Electronic Journal
The oxidoreductase CLIC4 controls UCP-2 expression to support mitochondrial function in macrophages
The Chloride Intracellular Channel-4 (CLIC4) is one of six highly conserved proteins in the CLIC family that share high structural homology with glutathione-S-transferase (GST)-omega in the GST superfamily. While CLIC4 is a multifunctional protein that resides in multiple cellular compartments, the discovery of its enzymatic glutaredoxin-like activity in vitro suggested that it could be one of the essential oxidoreductases in cells. Here we show that macrophages lacking Clic4 display a variety of phenotypes including a failure to sustain cytokine production and reduced phagocytosis suggesting a role for Clic4 in metabolic fitness. Null cells have elevated levels of ROS as well as defective cellular energetics and reduced ATP levels. Mechanistically we find that stimulated Clic4 null cells have exacerbated expression of the negative regulator of mitochondrial ROS, UCP2. Accordingly, inhibition of UCP2 restores macrophage energetics and phagocytic activity in vitro and in vivo. We propose a model where Clic4 restrains UCP2 expression by dampening cellular ROS levels thereby preserving the mitochondrial function necessary for highly energetic activities including sustained cytokine production and phagocytosis. Our findings raise the possibility of targeting CLIC4 to induce macrophage hypophagia as a mechanism of innate immune exhaustion to improve some essential therapeutic outcomes for inflammatory diseases and related cancers.
- 13 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessThe oxidoreductase CLIC4 controls UCP-2 expression to support mitochondrial function in macrophages
The Chloride Intracellular Channel-4 (CLIC4) is one of six highly conserved proteins in the CLIC family that share high structural homology with glutathione-S-transferase (GST)-omega in the GST superfamily. While CLIC4 is a multifunctional protein that resides in multiple cellular compartments, the discovery of its enzymatic glutaredoxin-like activity in vitro suggested that it could be one of the essential oxidoreductases in cells. Here we show that macrophages lacking Clic4 display a variety of phenotypes including a failure to sustain cytokine production and reduced phagocytosis suggesting a role for Clic4 in metabolic fitness. Null cells have elevated levels of ROS as well as defective cellular energetics and reduced ATP levels. Mechanistically we find that stimulated Clic4 null cells have exacerbated expression of the negative regulator of mitochondrial ROS, UCP2. Accordingly, inhibition of UCP2 restores macrophage energetics and phagocytic activity in vitro and in vivo. We propose a model where Clic4 restrains UCP2 expression by dampening cellular ROS levels thereby preserving the mitochondrial function necessary for highly energetic activities including sustained cytokine production and phagocytosis. Our findings raise the possibility of targeting CLIC4 to induce macrophage hypophagia as a mechanism of innate immune exhaustion to improve some essential therapeutic outcomes for inflammatory diseases and related cancers.
- Open Access
- 29 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from 3D “Emboli” Culture Models Epithelial Breast Cancer Cell Oxidative Mitochondrial Metabolism with Relevance for Lung Metastasis
Emboli formation by different breast cancer cell lines
- 29 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from 3D “Emboli” Culture Models Epithelial Breast Cancer Cell Oxidative Mitochondrial Metabolism with Relevance for Lung Metastasis
Emboli formation by different breast cancer cell lines
- Open Access
- 29 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from 3D “Emboli” Culture Models Epithelial Breast Cancer Cell Oxidative Mitochondrial Metabolism with Relevance for Lung Metastasis
Proteomic and metabolic analysis
- 29 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from 3D “Emboli” Culture Models Epithelial Breast Cancer Cell Oxidative Mitochondrial Metabolism with Relevance for Lung Metastasis
Proteomic and metabolic analysis
- Open Access
- 29 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from 3D “Emboli” Culture Models Epithelial Breast Cancer Cell Oxidative Mitochondrial Metabolism with Relevance for Lung Metastasis
Treatment of cells in 3D with metabolic pathway inhibitors
- 29 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from 3D “Emboli” Culture Models Epithelial Breast Cancer Cell Oxidative Mitochondrial Metabolism with Relevance for Lung Metastasis
Treatment of cells in 3D with metabolic pathway inhibitors
- Open Access
- 29 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary File 3 from 3D “Emboli” Culture Models Epithelial Breast Cancer Cell Oxidative Mitochondrial Metabolism with Relevance for Lung Metastasis
Morphometric data of electron microscopy images
- 29 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary File 3 from 3D “Emboli” Culture Models Epithelial Breast Cancer Cell Oxidative Mitochondrial Metabolism with Relevance for Lung Metastasis
Morphometric data of electron microscopy images
- Open Access
- 29 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from 3D “Emboli” Culture Models Epithelial Breast Cancer Cell Oxidative Mitochondrial Metabolism with Relevance for Lung Metastasis
Ultrastructural analysis of SUM149 mitochondria, nuclei and lipid droplets
- 29 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from 3D “Emboli” Culture Models Epithelial Breast Cancer Cell Oxidative Mitochondrial Metabolism with Relevance for Lung Metastasis
Ultrastructural analysis of SUM149 mitochondria, nuclei and lipid droplets
- Open Access
- 29 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary File 4 from 3D “Emboli” Culture Models Epithelial Breast Cancer Cell Oxidative Mitochondrial Metabolism with Relevance for Lung Metastasis
Supplementary File 4 from 3D “Emboli” Culture Models Epithelial Breast Cancer Cell Oxidative Mitochondrial Metabolism with Relevance for Lung Metastasis
- 29 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary File 4 from 3D “Emboli” Culture Models Epithelial Breast Cancer Cell Oxidative Mitochondrial Metabolism with Relevance for Lung Metastasis
Supplementary File 4 from 3D “Emboli” Culture Models Epithelial Breast Cancer Cell Oxidative Mitochondrial Metabolism with Relevance for Lung Metastasis
- Open Access
- 29 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from 3D “Emboli” Culture Models Epithelial Breast Cancer Cell Oxidative Mitochondrial Metabolism with Relevance for Lung Metastasis
Single cell mRNA sequencing data of cells from 2D, SphC, and EmC
- 29 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from 3D “Emboli” Culture Models Epithelial Breast Cancer Cell Oxidative Mitochondrial Metabolism with Relevance for Lung Metastasis
Single cell mRNA sequencing data of cells from 2D, SphC, and EmC